This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briët, J. M.
Right arrow Articles by Kok, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briët, J. M.
Right arrow Articles by Kok, J. H.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 107 No. 4 April 2001, pp. 712-718

Neonatal Thyroxine Supplementation in Very Preterm Children: Developmental Outcome Evaluated at Early School Age

Received Aug 22, 2000; accepted Dec 18, 2000.

Judy M. Briët*, Aleid G. van Wassenaer*, Friedo W. DekkerDagger , Jan J. M. de Vijlder§, Anneloes van Baar*, and Joke H. Kok*

From the * Department of Neonatology, Dagger  Department of Clinical Epidemiology and Biostatistics, and § Department of Pediatric Endocrinology. Emma Children's Hospital Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Objective.  Transient hypothyroxinemia in very premature infants is associated with developmental problems. A randomized, placebo-controlled trial of thyroxine (T4) supplementation was conducted in a group of 200 infants <30 weeks' gestation. T4 supplementation improved mental outcome at 2 years old in children of 25/26 weeks' gestation only. The effect of T4 supplementation beyond 2 years of age is unknown. We present the effects of neonatal T4 supplementation on outcome at early school age.

Methods.  Standardized measurements were used to assess cognitive, behavioral, and motor outcome, as well as a qualitative assessment of neurologic functioning. Survivors of the T4 trial were assessed at the age of 5.7 years.

Results.  Ninety-nine percent of the 157 survivors participated. Outcome on all domains was comparable between the T4 group and placebo group. In children <27 weeks' gestation, a 10 IQ point difference was found in favor of the T4 group, whereas in children of 29 weeks' gestation, a difference of 15 IQ points was found in favor of the placebo group. Teachers' reports showed less behavioral problems in the T4-treated children of 25/26 weeks' gestation, but more behavioral problems in the T4-treated children of 27 weeks' gestation. Differences in motor outcome and neurologic outcome were in favor of the T4-treated children <29 weeks' gestation, but not of the T4-treated children of 29 weeks' gestation.

Conclusions.  We found benefits of T4 supplementation for children <29 weeks' gestation, and especially in children of 25/26 weeks' gestation. However, in children of 29 weeks' gestation T4 supplementation is associated with more developmental problems.  Key words:  thyroxine, premature infant, follow-up studies, neuropsychological tests, treatment outcome.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
I. Velasco, M. Carreira, P. Santiago, J. A. Muela, E. Garcia-Fuentes, B. Sanchez-Munoz, M. J. Garriga, M. C. Gonzalez-Fernandez, A. Rodriguez, F. F. Caballero, et al.
Effect of Iodine Prophylaxis during Pregnancy on Neurocognitive Development of Children during the First Two Years of Life
J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3234 - 3241.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. G. van Wassenaer, J. Westera, B. A. Houtzager, and J. H. Kok
Ten-Year Follow-up of Children Born at <30 Weeks' Gestational Age Supplemented With Thyroxine in the Neonatal Period in a Randomized, Controlled Trial
Pediatrics, November 1, 2005; 116(5): e613 - e618.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
A. L. van Baar, A. G. van Wassenaer, J. M. Briet, F. W. Dekker, and J. H. Kok
Very Preterm Birth is Associated with Disabilities in Multiple Developmental Domains
J. Pediatr. Psychol., April 1, 2005; 30(3): 247 - 255.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
S. R. Rose
Correlation of Preterm Thyroid Levels and Neurodevelopmental Outcome
AAP Grand Rounds, January 1, 2003; 9(1): 3 - 4.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. G. van Wassenaer, J. M. Briet, A. van Baar, B. J. Smit, P. Tamminga, J. J. M. de Vijlder, and J. H. Kok
Free Thyroxine Levels During the First Weeks of Life and Neurodevelopmental Outcome Until the Age of 5 Years in Very Preterm Infants
Pediatrics, September 1, 2002; 110(3): 534 - 539.
[Abstract] [Full Text] [PDF]